Saudi pharma group Jamjoom eyes $1.12bn from IPO

Saudi Arabia's Jamjoom Pharmaceuticals has announced the successful completion of the book-building for its IPO and has set the final price for its issue at SR60 per share, implying a market capitalisation of SR4.2 billion ($1.12 billion) at listing.

Related Keywords

Riyadh ,Ar Riya ,Saudi Arabia ,Saudi ,Jamjoom Pharma ,Al Faisaliah Group Holding Company ,Development Holding Company Sedco ,Saudi Exchange ,Capital Market Authority ,Saudi National Bank ,Jamjoom Pharmaceuticals Factory Company ,Development Holding Company ,Fransi Capital ,Rajhi Capital ,Saudi Fransi Capital ,Lead Manager ,Alrajhi Capital ,Banque Saudi Fransi ,Tradearabia ,Rade Arabia ,Iddle East Trade News ,Cc Business News ,Ndustry News ,Trade News ,Usiness Directory ,Enders ,Roject News ,Remium Content ,